Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
- Pro Football Hall of Famer and Ready to Rescue campaign spokesperson,
Emmitt Smith , and Release Recovery Founder/CEO,Zac Clark , plan to visit severalU.S. college campuses to educate on opioid emergency preparedness - New sponsorship of Mobilize Recovery's “Campus Surge” initiative brings addiction prevention and recovery support to higher education institutions
Despite encouraging data showing a decline in overdose deaths in 2024,i the dangers of the opioid crisis remain ever present. A recent report from
The new report identifies
"Having personally navigated the profound challenges of opioid dependency after brain surgery and supported so many truly incredible people on their sobriety journeys at Release Recovery, I know that opioid emergencies can happen to anyone, anywhere, at any time,” said
Opioid misuse and dependency is the highest among young adults ages 18 to 25,iii yet less than 15 percent of American college students know how to administer live-saving opioid reversal naloxone medications.iv In honor of IOAD’s focus on overdose prevention and to help close this gap, Emergent is also sponsoring Mobilize Recovery’s Campus Surge initiative, which will provide action-driven overdose education and harm reduction engagement across several additional college campuses nationwide. This year, Campus Surge will provide life-saving resources and prevention tools to schools at the start of the academic year to empower students to activate change.
“On International Overdose Awareness Day and every day, Emergent honors the countless lives lost from opioid overdoses, and is committed to leading and strengthening our efforts across the
Recognizing the signs of an opioid overdose/poisoning—such as trouble breathing, pinpoint pupils, and pale and clammy skin—and acting quickly can be the difference between successfully reversing the effects of a poisoning, and not.v Visit ReadytoRescue.com for additional education and resources, and to learn how to be prepared in an opioid overdose emergency with life-saving intranasal naloxone visit NARCAN.com (
About NARCAN® Nasal Spray
NARCAN® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
_____________________________
i https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2025/20250514.htm
ii https://americanaddictioncenters.org/rehab-guide/college
iii https://pmc.ncbi.nlm.nih.gov/articles/PMC8750763/
iv https://pubmed.ncbi.nlm.nih.gov/38648053/
v Product Monograph. 2025. NARCAN® Nasal Spray. Retrieved from https://narcannasalspray.ca/PM/NNS_EN.pdf.

Source: Emergent BioSolutions